Public Notices: Peak Powder River Resources, LLC (F031172/A0016113)
Clinical Efficacy Endpoints from the Phase 3 CANOPY Study Evaluating[...]
Pharmacokinetics and Serum Virus Neutralizing Antibody Titers Following[...]
09/20/2024 | Press release | Distributed by Public on 09/20/2024 14:28
Please select the service you want to use:
Smartlinks | Kayne Anderson Energy Infrastructure Fund Inc. | KA Fund Advisors LLC | Finance | Security Markets | Security Markets | Company News | Corporate Debt | Financial Services | Investment Services | Closed-End Funds | London Stock Exchange (LSE) | New York Stock Exchange (NYSE) | Frankfurt Stock Exchange | Stuttgart Stock Exchange | NYSE American | NYSE ARCA Equities | Cboe BZX Exchange | Cboe Off Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | FINRA Alternative Display Facility (ADF) | Investors Exchange (IEX) | Nasdaq BX | Nasdaq Intermarket | Nasdaq PSX | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact